Literature DB >> 27864829

Pediatric case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma forming a solitary skin tumor on the forearm.

Michio Tokuyama1, Yuta Kurashige1, Tami Ota1, Yasuaki Manabe1, Hanako Yamaoka1, Norihiro Ikoma1, Akiko Fukumura2, Michie Miyashita2, Keisuke Otsubo2, Tsuyoshi Morimoto2, Hiroyuki Mochizuki2, Natsuko Nakano3, Naoya Nakamura3, Akira Ozawa1, Tomotaka Mabuchi1.   

Abstract

A 5-year-old girl noticed a rapidly growing reddish nodule on her right forearm. Although oral antibiotics had been administrated for 2 weeks, the tumor enlarged. Skin biopsy revealed excessive infiltration of atypical neoplastic cells expressing CD4, CD30 and anaplastic lymphoma kinase (ALK). These histological and immunohistochemical findings were consistent with anaplastic large cell lymphoma (ALCL). Computed tomography showed multiple lymphadenopathy, but lymph node biopsy and bone marrow examination did not show any evidence of systemic dissemination. However, due to the positive results for ALK and multiple lymphadenopathy, we diagnosed ALK-positive ALCL forming a solitary skin tumor on the forearm. The patient received chemotherapy and presented marked improvement. This paper discusses the difficulty of diagnosing pediatric ALK-positive ALCL limited to the skin and reviews the medical published work.
© 2016 Japanese Dermatological Association.

Entities:  

Keywords:  anaplastic large cell lymphoma; anaplastic lymphoma kinase; chemotherapy; children; skin

Mesh:

Substances:

Year:  2016        PMID: 27864829     DOI: 10.1111/1346-8138.13688

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  1 in total

Review 1.  ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.

Authors:  Shamir Geller; Theresa N Canavan; Melissa Pulitzer; Alison J Moskowitz; Patricia L Myskowski
Journal:  Int J Dermatol       Date:  2017-10-23       Impact factor: 2.736

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.